PIKOVIT 1 mg/5 mL+ 0.6 mg/5 mL+ 1 µg/5 mL+ 5 mg/5 mL+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 mL+ 100 i.j./5 mL+ 900 i.j./5 mL sirup Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pikovit 1 mg/5 ml+ 0.6 mg/5 ml+ 1 µg/5 ml+ 5 mg/5 ml+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 ml+ 100 i.j./5 ml+ 900 i.j./5 ml sirup

krka farma d.o.o. sarajevo - askorbinska kiselina, dekspantenol, holekalciferol, nikotinamid, piridoksin, retinol, tiamin, vitamin b12, vitamin b2 - sirup - 1 mg/5 ml+ 0.6 mg/5 ml+ 1 µg/5 ml+ 5 mg/5 ml+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 ml+ 100 i.j./5 ml+ 900 i.j./5 ml - 5 ml sirupa (1 mjerna kašičica) sadrži: 900 i.j. retinol palmitat (vitamin a); 100 i.j. holekalciferol (vitamin d3); 50 mg askorbinska kiselina (vitamin c); 1 mg tiaminhidrohlorid (vitamin b1); 1 mg riboflavinfosfatnatrijum (vitamin b2); 0,6 mg vitamin b6 (piridoksinhidrohlorid); 1 mcg cijanokobalamin (vitamin b12); 5 mg nikotinamid; 2 mg dekspantenol

PIKOVIT forte 5000 i.j./1 tableta+ 400 i.j./1 tableta+ 60 mg/1 tableta+ 1.5 mg/1 tableta+ 1.7 mg/1 tableta+ 2 mg/1 tableta+ 6 µg Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pikovit forte 5000 i.j./1 tableta+ 400 i.j./1 tableta+ 60 mg/1 tableta+ 1.5 mg/1 tableta+ 1.7 mg/1 tableta+ 2 mg/1 tableta+ 6 µg

krka farma d.o.o. sarajevo - askorbinska kiselina, folna kiselina, kalcijumpantotenat, nikotinamid, piridoksin, retinol, riboflavin, tiamin, vitamin b12, vitamin d3, vitamin e - obložena tableta - 5000 i.j./1 tableta+ 400 i.j./1 tableta+ 60 mg/1 tableta+ 1.5 mg/1 tableta+ 1.7 mg/1 tableta+ 2 mg/1 tableta+ 6 µg/1 tableta+ 20 - 1 obložena tableta sadrži: 5000 iu vitamina a (u obliku retinol palmitata); 400 iu holekalciferola (vitamin d3); 60 mg askorbinske kiseline; 20 mg nikotinamida; 15 mg αtokoferil acetata (vitamin e); 10 mg kalcijumpantotenata; 2 mg piridoksin idrohlorida (vitamin b6); 1,7 mg riboflavina (vitamin b2); 1,5 mg tiamin nitrata (vitamin b1); 0,4 mg folne kiseline; 6 mcg cijanokobalamina (vitamin b12).

PIKOVIT 1 mg/5 mL+ 0.6 mg/5 mL+ 1 µg/5 mL+ 5 mg/5 mL+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 mL+ 100 i.j./5 mL+ 900 i.j./5 mL sirup Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pikovit 1 mg/5 ml+ 0.6 mg/5 ml+ 1 µg/5 ml+ 5 mg/5 ml+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 ml+ 100 i.j./5 ml+ 900 i.j./5 ml sirup

krka farma d.o.o. sarajevo - askorbinska kiselina, dekspantenol, holekalciferol, nikotinamid, piridoksin, retinol, tiamin, vitamin b12, vitamin b2 - sirup - 1 mg/5 ml+ 0.6 mg/5 ml+ 1 µg/5 ml+ 5 mg/5 ml+ 2 mg/5 mg+ 1 mg/5 mg+ 50 mg/5 ml+ 100 i.j./5 ml+ 900 i.j./5 ml - 5 ml sirupa (1 mjerna kašičica) sadrži: 900 i.j. retinol palmitat (vitamin a); 100 i.j. holekalciferol (vitamin d3); 50 mg askorbinska kiselina (vitamin c); 1 mg tiaminhidrohlorid (vitamin b1); 1 mg riboflavinfosfatnatrijum (vitamin b2); 0,6 mg vitamin b6 (piridoksinhidrohlorid); 1 mcg cijanokobalamin (vitamin b12); 5 mg nikotinamid; 2 mg dekspantenol

MULTIVITAMIN INJECTION Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

multivitamin injection

medical intertrade d.o.o., dr. franje tuđmana 3, 10431 sveta nedelja, hrvatska - vitamin a ; kolekalciferol (vitamin d3) ; sav-rac-alfa-tokoferilacetat (vitamin e) ; tiaminklorid (vitamin b1) ; natrijev riboflavinfosfat (vitamin b2) ; piridoksinklorid (vitamin b6) ; nikotinamid ; dekspantenol ; cijanokobalamin (vitamin b12) - otopina za injekciju - vitamini i minerali - goveda, svinja, ovaca

Rivaroxaban Viatris (previously Rivaroxaban Mylan) Europska Unija - hrvatski - EMA (European Medicines Agency)

rivaroxaban viatris (previously rivaroxaban mylan)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotska sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Rivaroxaban Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

rivaroxaban accord

accord healthcare s.l.u. - rivaroksaban - acute coronary syndrome; coronary artery disease; peripheral arterial disease; venous thromboembolism; stroke; atrial fibrillation; pulmonary embolism - antitrombotska sredstva - prevencija venske tromboembolije (vte) u odraslih bolesnika koji se podvrgavaju izborni operacije zamjena kuka ili koljena. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. (see section 4. 4 for haemodynamically unstable pe patients. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. (see section 4. 4 za hemodinamski nestabilne ТЭЛА pacijenata). adultsprevention of stroke and systemic embolism in adult patients with non valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. rivaroxaban accord, co administered with acetylsalicylic acid (asa) alone or with asa plus ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers (see sections 4. 3, 4. 4 i 5. rivaroxaban accord, co administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Pregabalin Zentiva Europska Unija - hrvatski - EMA (European Medicines Agency)

pregabalin zentiva

zentiva, k.s. - pregabalin - anxiety disorders; epilepsy - antiepileptici sredstva, - neuropathic pain , pregabalin zentiva is indicated for the treatment of peripheral and central neuropathic pain in adults. , epilepsy , pregabalin zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. , generalised anxiety disorder , pregabalin zentiva is indicated for the treatment of generalised anxiety disorder (gad) in adults.

Karbamazepin Tillomed 200 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

karbamazepin tillomed 200 mg tablete s produljenim oslobađanjem

tillomed pharma gmbh, mittelstrasse 5/5a, schonefeld, njemačka - karbamazepin - tableta s produljenim oslobađanjem - 200 mg - urbroj: svaka obložena tableta sadrži 200 mg karbamazepina

Karbamazepin Tillomed 400 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

karbamazepin tillomed 400 mg tablete s produljenim oslobađanjem

tillomed pharma gmbh, mittelstrasse 5/5a, schonefeld, njemačka - karbamazepin - tableta s produljenim oslobađanjem - 400 mg - urbroj: svaka obložena tableta sadrži 400 mg karbamazepina

Aban 10 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

aban 10 mg filmom obložene tablete

alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - rivaroksaban - filmom obložena tableta - 10 mg - urbroj: jedna filmom obložena tableta sadrži 10 mg rivaroksabana